Phase 3 trials are designed to determine whether the drug is safe and effective for the indicated use. Which phase is this?

• A. Phase 1
• B. Phase 2
• C. Phase 3
• D. Phase 4

Answer: (C)

In drug development, later-stage trials are all about confirming that a drug works for its intended use and that its risks are acceptable in a larger, more diverse group of patients. This phase is designed to test the drug in a substantial number of patients with the condition, often including a comparison to standard therapy, to determine whether there is real, reproducible benefit and to characterize the safety profile more fully. The results from these trials provide the robust data needed for regulatory approval and labeling. Earlier phases focus on safety and dosing in small groups (Phase I) and initial efficacy and safety signals in patients (Phase II), while post-marketing surveillance happens after approval (Phase IV).